Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
188 studies found for:    "Meningococcal infection"
Show Display Options
Rank Status Study
1 Completed Creation of a Biotheque of Patients of Seine-Maritime With Meningococcal Infection
Condition: Meningococcal Infections
Intervention:
2 Completed Comparison of GSK134612 in Subjects Previously Vaccinated Against Meningococcal Disease Versus Non-vaccinated Subjects
Condition: Meningococcal Disease
Intervention: Biological: Meningococcal vaccine GSK134612
3 Completed Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older
Conditions: Meningitis;   Meningococcal Meningitis;   Meningococcal Infections;   Invasive Meningococcal Disease
Interventions: Biological: MenACYW Conjugate Vaccine;   Biological: Meningococcal Polysaccharide Vaccine Groups A, C, Y, W 135 Combined
4 Completed A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine (TetraMen-T) in Infants and Toddlers
Conditions: Meningitis;   Meningococcal Infection
Interventions: Biological: Meningococcal Polysaccharide Tetanus Protein Conjugate;   Biological: Pentacel®, M-M-R®II, Varivax®, Prevnar®, RotaTeq®, Engerix-B®
5 Completed
Has Results
Study of Two Doses of Menactra® or One Dose of Monovalent Meningococcal Group C Vaccine With Routine Immunizations
Conditions: Meningitis;   Meningococcal Infection
Interventions: Biological: Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate: Menactra®;   Biological: Meningococcal Group C Conjugate vaccine: MenC
6 Enrolling by invitation Post-licensure Safety Surveillance Study of Menactra Vaccine When Administered As a 2-dose Schedule to Children
Conditions: Meningitis;   Meningococcal Infection
Intervention: Biological: Menactra®: Meningococcal Polysaccharide Diphtheria Toxoid Conjugate
7 Active, not recruiting Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of Age
Conditions: Meningitis;   Meningococcal Infection;   Diphtheria;   Tetanus;   Pertussis;   Haemophilus Influenzae Serotype b (Hib)
Interventions: Biological: Meningococcal polysaccharide diphtheria toxoid conjugate;   Biological: Meningococcal polysaccharide diphtheria toxoid conjugate + Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed;   Biological: Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate
8 Completed
Has Results
Persistence of Antibodies in Adolescents and Adults 15 to 23 Years Who Received One Dose of Menactra® or Menomune®
Conditions: Meningitis;   Meningococcal Infection
Intervention: Biological: Meningococcal Polysaccharide Diphtheria Toxoid Conjugate
9 Completed
Has Results
A Study of Meningococcal Vaccine, Menactra® in Healthy Subjects in India
Conditions: Meningococcal Infection;   Meningitis
Intervention: Biological: Meningococcal Polysaccharide Diphtheria Toxoid Conjugate (Menactra®)
10 Active, not recruiting Immunogenicity and Safety of Menactra® Vaccine in Subjects Aged 9 to 23 Months in India and in the Russian Federation
Conditions: Meningitis;   Meningococcal Infection
Intervention: Biological: Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine
11 Completed
Has Results
Persistence of Antibodies in Children Aged 7 to 15 Years Who Previously Received One Dose of Menactra® or Menomune®
Conditions: Meningitis;   Meningococcal Infection
Intervention: Biological: Polysaccharide Diphtheria Conjugate Vaccine
12 Completed
Has Results
Study of a Single Dose of Menactra® Vaccine 4-6 Years After Prior Menactra Vaccine
Conditions: Meningitis;   Meningococcal Infection
Intervention: Biological: Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate: Menactra®
13 Completed
Has Results
Antibody Persistence and Response to Re-vaccination With Either Menactra® or Menomune® 3 Years After Initial Vaccination
Conditions: Meningitis;   Meningococcal Meningitis;   Meningococcal Infections
Interventions: Biological: Menomune®: A, C, Y, W 135 Meningococcal Polysaccharide;   Biological: Menactra®: Meningococcal (A, C, Y and W 135) Polysaccharide Diphtheria Toxoid Conjugate
14 Completed
Has Results
Persistence of Bactericidal Antibodies in Adolescents and Adults Who Had Received a Single Dose of Menactra® Vaccine
Conditions: Meningococcal Infections;   Meningitis
Interventions: Biological: Menactra®;   Biological: Menomune®
15 Recruiting Septic cArdiac Deficiency and MenIngococcal seveRe Sepsis
Conditions: Meningococcal Infections;   Septic Shock;   Severe Sepsis
Intervention: Biological: BNP
16 Completed
Has Results
Study of a Single Dose of Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine (SP284) in Japanese Subjects
Conditions: Meningitis;   Meningococcal Meningitis;   Meningococcal Infections
Intervention: Biological: Meningococcal polysaccharide diphtheria toxoid conjugate
17 Completed
Has Results
Safety and Immunogenicity of Intradermal Versus Subcutaneous Doses of Menomune®
Conditions: Meningococcal Infections;   Meningitis
Intervention: Biological: Meningococcal Polysaccharide Groups A\C\Y\W-135 Combined
18 Completed
Has Results
Study of a Tetravalent Meningococcal Diphtheria Toxoid Conjugate Vaccine in Toddlers 9 to 18 Months of Age
Conditions: Meningitis;   Meningococcal Infection
Interventions: Biological: Meningococcal Polysaccharide Diphtheria Protein Conjugate (Menactra®);   Biological: A/C/Y/W-135, Meningococcal Polysaccharide Vaccine (Menomune®)
19 Completed Safety, Tolerability and Immunogenicity of Meningococcal C Conjugate Vaccine to Children 32 to 40 Months of Age
Condition: Meningococcal Infection
Intervention: Biological: Meningococcal C conjugate vaccine
20 Completed
Has Results
Dose Comparison Study of Menactra® in US Children
Conditions: Meningitis;   Meningococcal Infection;   Neisseria Meningitidis
Intervention: Biological: Menactra®: Meningococcal Polysaccharide Diphtheria Conjugate

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years